NCT03696550 - A Safety and PK Study of IV Eravacycline | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

March 14, 2021

Study Completion Date

March 19, 2021

Conditions

Bacterial Infections

Interventions

DRUG

Eravacycline (TP-434)

"Subjects will be stratified by age into 2 cohorts, as follows:~* Cohort 1: from 12 to \<18 years of age (N=8)~* Cohort 2: from 8 to \<12 years of age (N=12 or at least 60% of subjects)"

Trial Locations (7)

26506

West Virginia University Hospital, Morgantown

27710

Duke University Medical Center, Durham

44106

University Hospitals Cleveland Medical Center, Rainbow Babies and Children's Hospital, Cleveland

60611

Lurie Children's Hospital, Chicago

71103

Louisiana State University Health Sciences Center, Shreveport

90095

Ronald Reagan University of California Los Angeles Medical Center, Los Angeles

02111

Tufts Medical Center, Boston

All Listed Sponsors

lead

Tetraphase Pharmaceuticals, Inc

INDUSTRY